Exploring the modulatory effects of sotagliflozin on dyslipidemia in mice: The role of glucagon, fibroblast growth factor 21 and glucagon‐like peptide 1
Article in Clinical and Experimental Pharmacology and Physiology (March 2024)
The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.
Article in Clinical and Experimental Pharmacology and Physiology (March 2024)
Article in Actualités Pharmaceutiques (January 2024)
Article in International Journal of Molecular Sciences (June 2023)